{"schema_version":"1.0","type":"article","title":"亞馬遜（Amazon） 參戰 AI 製藥，挑戰輝達（Nvidia）","url":"https://drugnews.com.tw/articles/2026-04-30-amazon-ai-nvidia.html","markdown_url":"https://drugnews.com.tw/articles/2026-04-30-amazon-ai-nvidia.md","lang":"zh-Hant","date":"2026-04-30","publish_at":"2026-04-30T10:30:00+08:00","updated_at":"2026-04-30","category":"商業分析系列","topic":"商業分析系列","tags":["商業分析系列","免費文章","AI","BD","生技投資","製藥巨頭"],"summary":"過去幾年，科技巨頭切入生命科學，大多還停留在兩個角色：一種是賣算力，另一種是賣通用 AI。真正難的，是再往前跨一步，直接碰觸藥物發現這個最核心、也最挑剔的環節。因為這不只是把模型丟給研究員用而已，而是要同時解決模型選擇、資料標準、實驗流程、濕實驗驗證、結果回流與團隊協作這一整串問題。","key_points":[],"facts":[],"sections":["不只賣雲，Amazon 也要下場定義 AI 製藥：40+ 生物模型、抗體基準資料庫與 lab-in-the-loop，亞馬遜想吃下的是新藥研發的作業系統","01｜它不是在賣模型，而是在解組織瓶頸","02｜先從抗體下手，因為這是最適合做閉環的場景","03｜真正重要的，可能不是平台本身，而是那套 benchmark","04｜Amazon 真正想搶的，不是工具，而是作業系統位置","05｜它踩中的，不只是技術點，而是整個產業關係的轉折點","06｜最後還是要潑一點冷水"],"references":[{"title":"[0]: 各公司官網＆公開資料","source":"","date":"","url":""},{"title":"[1]:","source":"","date":"","url":""},{"title":"Learn about the general availability of Amazon Bio Discovery, a unified application that closes the experimental loop between your dry and wet lab, enabling you to collaborate more efficiently with your computational colleagues, compress discovery cycles,","source":"","date":"","url":""},{"title":"aws.amazon.com","source":"","date":"","url":""},{"title":"[2]:","source":"","date":"","url":""},{"title":"了解製藥、生物技術、基因體和醫療保健供應商與保險業者的雲端技術應用現況。使用 AWS 雲端，將大數據分析中的創新、高效能運算、機器學習融入您的組織。","source":"","date":"","url":""},{"title":"aws.amazon.com","source":"","date":"","url":""},{"title":"[3]:","source":"","date":"","url":""},{"title":"Learn about the general availability of Amazon Bio Discovery, a unified application that closes the experimental loop between your dry and wet lab, enabling you to collaborate more efficiently with your computational colleagues, compress discovery cycles,","source":"","date":"","url":""},{"title":"aws.amazon.com","source":"","date":"","url":""},{"title":"\"Introducing Amazon Bio Discovery","source":"AWS for Industries\"","date":"","url":""},{"title":"[4]:","source":"","date":"","url":""},{"title":"reuters.com","source":"","date":"","url":""},{"title":"https://www.reuters.com/business/healthcare-pharmaceuticals/amazon-launches-ai-research-tool-speed-early-stage-drug-discovery-2026-04-14/","source":"","date":"","url":"https://www.reuters.com/business/healthcare-pharmaceuticals/amazon-launches-ai-research-tool-speed-early-stage-drug-discovery-2026-04-14/"},{"title":"www.reuters.com","source":"","date":"","url":""},{"title":"\"Amazon launches AI research tool to speed early-stage drug discovery","source":"Reuters\"","date":"","url":""},{"title":"[5]:","source":"","date":"","url":""},{"title":"Design Better Antibodies with AI-Powered Lab-in-the-Loop Workflows","source":"","date":"","url":""},{"title":"aws.amazon.com","source":"","date":"","url":""},{"title":"\"Amazon Bio Discovery\"","source":"","date":"","url":""}],"images":[{"alt":"Dcard 原圖：亞馬遜（Amazon） 參戰 AI 製藥，挑戰輝達（Nvidia）（圖 1）","url":"https://drugnews.com.tw/assets/articles/amazon-ai-nvidia/dcard-01.webp"},{"alt":"Dcard 原圖：亞馬遜（Amazon） 參戰 AI 製藥，挑戰輝達（Nvidia）（圖 2）","url":"https://drugnews.com.tw/assets/articles/amazon-ai-nvidia/dcard-02.webp"},{"alt":"Dcard 原圖：亞馬遜（Amazon） 參戰 AI 製藥，挑戰輝達（Nvidia）（圖 3）","url":"https://drugnews.com.tw/assets/articles/amazon-ai-nvidia/dcard-03.png"}],"cover_image":"https://drugnews.com.tw/assets/articles/amazon-ai-nvidia/dcard-01.webp","publisher":{"name":"Drugnews｜藥時事","url":"https://drugnews.com.tw/","profile":"https://drugnews.com.tw/brand-profile.json"},"citation":"Drugnews｜藥時事（2026-04-30）。亞馬遜（Amazon） 參戰 AI 製藥，挑戰輝達（Nvidia）。https://drugnews.com.tw/articles/2026-04-30-amazon-ai-nvidia.html","disclaimer":"本文僅供產業研究與知識分享，不構成投資、醫療、募資或個股建議。","translations":{"en":"2026-04-30-amazon-ai-nvidia-en.html"},"relationship":"independent_editorial","disclosure_url":"https://drugnews.com.tw/policy/"}